Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment

BACKGROUND: Men are three to four times more likely to be diagnosed with bladder cancer (BCa) than women, who often have more aggressive tumors. Intravesical bacillus Calmette-Guerin (BCG) for non–muscle-invasive bladder cancer (NMIBC) is one of the first immunotherapies, with use of immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Besançon, Marjorie, Gris, Typhaine, Joncas, France-Hélène, Picard, Valérie, Bergeron, Alain, Fradet, Yves, Toren, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Bladder Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557088/
https://www.ncbi.nlm.nih.gov/pubmed/36246841
http://dx.doi.org/10.1016/j.euros.2022.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557088/
https://www.ncbi.nlm.nih.gov/pubmed/36246841
http://dx.doi.org/10.1016/j.euros.2022.06.007

Ejemplares similares